Press release
One "Target" for a Month: Creative Biolabs Features TNFRSF9
New York, USA - July 10, 2024 - The growing interest in TNFRSF9 (also known as CD137, 4-1BB) stems from its role as a co-stimulatory receptor on T cells, which can enhance immune responses against tumors. Research has shown that activating TNFRSF9 can significantly boost the efficacy of cancer immunotherapies. To synchronize with recent industry news highlighting the potential of TNFRSF9-targeted therapies to overcome the limitations of existing treatments and deliver durable anti-tumor responses, Creative Biolabs specifies their anti-TNFRSF9 engineered antibodies [https://www.creativebiolabs.net/symbolsearch_TNFRSF9_2.htm] in the monthly briefing.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
I: Leading in with the Omnipresent Hi-Affi Trademark
"First of all, a short overview of our Hi-Affi Trademark platform to get you a clearer picture of our antibody performance," according to the scientist delivering the presentation, "which is a concert of advanced DNA technologies and powerful cell-free expression systems."
Almost all production work of recombinant antibodies [https://www.creativebiolabs.net/hi-affi-tm-recombinant-antibodies.htm] is run by the Hi-Affi Trademark platform, covering antibodies of different working modalities (blocking, neutralizing, etc.), antibodies against divergent targets (epitope-specific, mRNA encoded, etc.), and antibodies originated from different species (chicken, rabbit, etc.), with which the yielding reagents will be validated to have over 98% purity, high affinity, and reproducibility.
II: Catalog presentation
The scientist revealed a list of their research-use-only antibodies that are readily available for global delivery, and announced that the list is growing to cover more isotypes and more validated applications.
* Rat Anti-TNFRSF9 Recombinant Antibody
* Recombinant Mouse Anti-Human TNFRSF9 Antibody
* Hamster Anti-TNFRSF9 Recombinant Antibody
* Rat Anti-TNFRSF9 Recombinant Antibody
* Rat Anti-TNFRSF9 Recombinant Antibody
* Human Anti-TNFRSF9 Recombinant Antibody
* Human Anti-TNFRSF9 Recombinant Antibody
III: Case study: urelumab-a therapeutic breakthrough
Furthermore, a candidate that had received its final clinical results not a while ago was discussed-urelumab, an agonistic antibody targeting 4-1BB, making it a valuable tool in the fight against cancer. Two studies that evaluated urelumab in combination with cetuximab or nivolumab in patients with select, advanced solid tumors were reported in the paper.
"For relevant studies, we have anti-human 4-1BB recombinant antibodies [https://www.creativebiolabs.net/Anti-Human-4-1BB-Therapeutic-Antibody-Urelumab-13548.htm]," the scientist added, "which have been validated to be positive against native human antigen. Tested data are provided on the product page to help researchers know more about how they work in specific assays, like WB and ELISA."
IV: Outlook
Creative Biolabs prides itself on its commitment to innovation and collaboration and is poised to play a pivotal role in advancing TNFRSF9-targeted therapies.
"As the research community continues to explore the full potential of such critical factors in immunotherapy, we remain dedicated to driving scientific progress." The scientist summarized.
For more information about Creative Biolabs' TNFRSF9 antibodies and to explore their comprehensive product offerings, visit https://www.creativebiolabs.net or contact their expert team.
Company Overview
Creative Biolabs is a biotechnology company specializing in antibody development, engineering, and production. With a strong focus on innovation and customer service, Creative Biolabs provides a wide range of high-quality antibody products to support biomedical research and drug development worldwide.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=one-target-for-a-month-creative-biolabs-features-tnfrsf9]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creativebiolabs.net
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release One "Target" for a Month: Creative Biolabs Features TNFRSF9 here
News-ID: 3575212 • Views: …
More Releases from Getnews
gardenLAB Expands Thoughtful Landscape Design Services in Dallas, TX
Image: https://www.globalnewslines.com/uploads/2026/02/1771523043.jpg
gardenLAB, a Dallas-based landscape design studio, continues to shape resilient and design-forward outdoor spaces across North Texas. Known for a refined, site-responsive approach, gardenLAB delivers landscapes that balance aesthetics, function, and long-term adaptability to the regional climate.
February 20, 2026 - Dallas, TX - With a focus on integrated planning and horticultural expertise, gardenLAB supports residential and commercial properties through services aligned with Groundskeeping Dallas [https://www.gardenlab.design/services#:~:text=GARDENING%20%26%20SEASONAL%20COLOR] standards, ensuring landscapes remain…
Let Kids Be Kids, Arshiner's 2026 Spring/Summer Collection Brings Festive Joy in …
In 2026, American parents' approach to choosing children's clothing is undergoing a quiet transformation. Instead of focusing on outfits for specific festive occasions to create a sense of ritual, they are now embracing real-life daily scenarios. During those moments of running, exploring, laughing, and growing, clothing should be an extension of joy and freedom. At the heart of this trend is the idea that children should not only shine on…
"One Outfit, Multiple Wears" Becomes a New Travel Trend: EKOUAER Travel Homewear …
From an overstuffed suitcase that's hard to zip up, to tight outfits on the plane that make it difficult to breathe, to the moment when you check into a hotel and want to go out for a cup of coffee but can't find a comfortable and appropriate outfit... At such times, we often lament: A truly enjoyable journey really requires a set of homewear that can "go wherever you go."…
HowtoAchieveBothSafetyandComfortinSpringandSummerClose-to-SkinOutfits, COOFANDYO …
Image: https://www.globalnewslines.com/uploads/2026/02/14ee3a9cbf6b505268b80216af836535.jpg
As temperatures gradually warm, spring and summer styling has become a focus in men's daily dressing. Compared to autumn and winter, spring and summer clothing is lighter, thinner, and more close-fitting, with longer and more extensive contact with the skin. This shift has led people to pay greater attention to the safety, comfort, and breathability of clothing materials. When garments almost become a "second skin," factors such as skin-friendliness,…
More Releases for TNFRSF9
Tumor Necrosis Factor Receptor Superfamily Member 9: North America to Retain its …
Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9) pipeline Target constitutes close to 35 molecules. Out of which approximately 31 molecules are developed by companies and remaining by the universities/institutes.
To evaluate factors influencing Tumor Necrosis Factor Receptor Superfamily Member 9, Market Research Hub (MRH) has included a report titled “Tumor Necrosis Factor Receptor…
